Financière de Tubize SA

EBR:TUB.BR

105.2 (EUR) • At close June 21, 2024
Bedrijfsnaam Financière de Tubize SA
Symbool TUB.BR
Munteenheid EUR
Prijs 105.2
Beurswaarde 4,682,725,520
Dividendpercentage 1.02%
52-weken bereik 60.8 - 109.2
Industrie Biotechnology
Sector Healthcare
CEO Ms. Anne Sophie Pijcke
Website https://www.financiere-tubize.be

An error occurred while fetching data.

Over Financière de Tubize SA

Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic

Vergelijkbare Aandelen

Laboratorios Farmaceuticos Rovi, S.A. logo

Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC

82.2 EUR

Qualicorp Consultoria e Corretora de Seguros S.A. logo

Qualicorp Consultoria e Corretora de Seguros S.A.

QUAL3.SA

1.41 BRL

Virbac SA logo

Virbac SA

VIRP.PA

352 EUR

Oncoclínicas do Brasil Serviços Médicos S.A. logo

Oncoclínicas do Brasil Serviços Médicos S.A.

ONCO3.SA

5.67 BRL

Empreendimentos Pague Menos S.A. logo

Empreendimentos Pague Menos S.A.

PGMN3.SA

2.21 BRL

Ramsay Générale de Santé SA logo

Ramsay Générale de Santé SA

GDS.PA

16 EUR

Kora Saúde Participações S.A. logo

Kora Saúde Participações S.A.

KRSA3.SA

0.56 BRL

Haw Par Corporation Limited logo

Haw Par Corporation Limited

H02.SI

9.77 SGD

Summerset Group Holdings Limited logo

Summerset Group Holdings Limited

SUM.NZ

9.72 NZD

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)